Nivolumab 40mg/4ml Injection – Nivamo (Imported)

Product Overview

Nivamo 40mg/4ml Injection is an imported oncology medicine containing Nivolumab, a monoclonal antibody used in cancer immunotherapy. It is manufactured by Ziska Pharmaceuticals Limited, Bangladesh, and is intended for use under the supervision of a qualified oncologist. Nivamo belongs to a class of medicines known as immune checkpoint inhibitors, which help the body’s immune system recognize and attack cancer cells.

MedicineWalyDost.com helps patients and caregivers access imported and specialty medicines in Pakistan, subject to availability and prescription requirements.

Product Information

• Brand Name: Nivamo
• Generic Name: Nivolumab
• Strength: 40mg/4ml
• Dosage Form: Injection / concentrate for intravenous infusion
• Manufacturer: Ziska Pharmaceuticals Limited
• Origin: Bangladesh
• Pack Size: 1 injection (single-dose vial)
• Therapeutic Category: Oncology / Cancer Immunotherapy
• Availability: Imported; subject to current stock and sourcing
• Prescription Required: Yes

What Is Nivamo (Nivolumab) Used For?

Nivolumab is an immunotherapy medicine used for certain cancers. Its suitability depends on the cancer type, stage, previous treatments, relevant laboratory or tumour-marker results, and the treating oncologist’s assessment. Depending on the approved indication and treatment plan, nivolumab may be used for:

• Melanoma: Certain advanced or metastatic cases and selected situations after surgery.
• Non-small cell lung cancer (NSCLC): Selected cases, sometimes in combination with other anticancer medicines.
• Renal cell carcinoma: Certain types of advanced kidney cancer.
• Classical Hodgkin lymphoma: Selected patients whose disease meets treatment criteria.
• Head and neck cancer: Certain recurrent or metastatic cases.
• Other eligible cancers: Nivolumab also has indications in selected settings involving other tumour types, depending on the applicable prescribing information and local approval.

Not every patient with these cancers is eligible for nivolumab. Treatment selection must be made by an oncology specialist.

How Does Nivolumab Work?

Nivolumab is a programmed death receptor-1 (PD-1) immune checkpoint inhibitor. Some cancer cells use the PD-1 pathway to reduce the immune system’s ability to attack them. Nivolumab blocks PD-1 signalling, which can help restore immune activity against cancer cells.

Unlike conventional chemotherapy, nivolumab works by modifying an immune response rather than directly targeting rapidly dividing cells in the same way. Its effectiveness and side-effect profile are different from those of traditional chemotherapy. It may be prescribed alone or alongside other treatments when clinically appropriate.

Dosage and Administration

Nivamo 40mg/4ml is intended for intravenous infusion by trained healthcare professionals in an appropriate clinical setting. It must not be self-injected or administered at home without a properly authorized clinical service.

The dose and infusion schedule vary according to the cancer being treated, the patient’s age and clinical condition, and whether nivolumab is used alone or in combination with other medicines. The 40mg vial strength does not mean that one vial is necessarily a complete treatment dose.

Only the treating oncologist should determine the dose, treatment interval, duration, and any changes to the treatment plan. Do not change or discontinue treatment without medical advice.

Possible Side Effects

Nivolumab can cause side effects, including reactions caused by increased immune activity. Commonly reported effects may include:

• Tiredness or weakness
• Skin rash or itching
• Diarrhoea
• Nausea
• Muscle, joint, or back pain
• Reduced appetite
• Cough or shortness of breath
• Fever or headache

Serious Warnings

Nivolumab can sometimes cause severe or life-threatening immune-related complications affecting the lungs, intestines, liver, kidneys, skin, thyroid, adrenal glands, pituitary gland, heart, or nervous system.

Seek urgent medical assessment for breathing difficulty, persistent or severe diarrhoea, blood in stools, severe abdominal pain, yellowing of the skin or eyes, reduced urine output, unusual severe weakness, chest pain, confusion, or a serious rash. Severe allergic or infusion reactions also require immediate medical attention.

Side effects may occur during treatment or even after treatment has ended. Report new or worsening symptoms promptly to the oncology team.

Precautions and Contraindications

Before starting treatment, inform the oncologist about all existing medical conditions and medicines, including:

• Previous organ or stem-cell transplantation
• Autoimmune disorders or immune-system conditions
• Previous immune-related reactions to cancer treatment
• Liver or kidney problems
• Lung disease or previous pneumonitis
• Pregnancy, plans for pregnancy, or breastfeeding
• All prescription medicines, over-the-counter products, and supplements being used

Nivolumab may harm an unborn baby. Patients who could become pregnant should discuss effective contraception and the recommended period after treatment with their oncologist. Breastfeeding should also be discussed with the treating specialist.

The treating team may order blood tests and other assessments before and during treatment to monitor for adverse effects. Do not receive Nivamo without a confirmed prescription and specialist treatment plan.

Storage and Handling

Nivolumab is a temperature-sensitive biologic medicine. Follow the storage instructions printed on the specific product pack and its prescribing information. Standard nivolumab products are generally refrigerated at 2°C to 8°C, protected from light, and must not be frozen or shaken. The medicine should be transported using an appropriate cold chain.

Do not use a vial if its packaging is damaged, its seal appears compromised, or there is a concern about storage or transport conditions. Confirm product integrity and suitability with a qualified pharmacist or healthcare professional before administration.

Nivamo 40mg/4ml Injection Price in Pakistan

The price of Nivamo 40mg/4ml Injection in Pakistan may vary depending on import availability, supplier, batch, and sourcing conditions. Contact MedicineWalyDost.com to confirm the latest price, availability, and delivery arrangements before placing an order.

Buy Nivamo 40mg/4ml Injection Online in Pakistan

MedicineWalyDost.com assists customers seeking imported oncology and specialty medicines in Pakistan. If your oncologist has prescribed Nivamo (Nivolumab) 40mg/4ml Injection, contact our team to check current availability and pricing.

How to place an order:

1. Share a valid prescription for verification.
2. Confirm the required medicine, quantity, and delivery address with our support team.
3. Complete payment by bank transfer to the official business account after order confirmation.
4. Allow approximately 2–3 business days for delivery after payment confirmation, subject to availability and delivery conditions.

We require advance payment and do not offer cash on delivery (COD). Nationwide delivery arrangements can be confirmed with our team.

Contact MedicineWalyDost.com

• WhatsApp: 0315 7733383
• Website: MedicineWalyDost.com
• Email: Info@medicineWalyDost.com

Prescription-only medicine. For use under an oncologist’s supervision. Product availability, pack details, and cold-chain suitability must be confirmed before ordering.

Frequently Asked Questions

1. What is Nivamo 40mg/4ml Injection?

Nivamo is a brand of nivolumab, an immune checkpoint inhibitor used for selected cancer indications under specialist supervision.

2. Who manufactures Nivamo?

Nivamo is listed by Ziska Pharmaceuticals Limited, Bangladesh. Check the supplied pack and product documentation to confirm the manufacturer and batch details.

3. Is Nivamo used for all types of cancer?

No. Nivolumab is approved for specific cancers and treatment settings. An oncologist must determine whether it is appropriate for an individual patient.

4. Can Nivamo be injected at home?

It is intended for intravenous infusion by trained healthcare professionals in an appropriate clinical setting. It should not be self-administered.

5. Does Nivamo require a prescription?

Yes. A valid prescription and an oncology specialist’s treatment plan are required.

6. How can I check Nivamo’s price in Pakistan?

Contact MedicineWalyDost.com on WhatsApp at 0315 7733383 for current pricing, availability, and delivery information.

7. How should Nivamo be stored?

Follow the specific product’s storage instructions. Nivolumab products generally require refrigeration at 2°C to 8°C, protection from light, and must not be frozen or shaken.